606 related articles for article (PubMed ID: 7505803)
41. Cyclic GMP and cGMP-binding phosphodiesterase are required for interleukin-1-induced nitric oxide synthesis in human articular chondrocytes.
Geng Y; Zhou L; Thompson WJ; Lotz M
J Biol Chem; 1998 Oct; 273(42):27484-91. PubMed ID: 9765278
[TBL] [Abstract][Full Text] [Related]
42. The anti-platelet agent, ticlopidine, upregulates interleukin-1-Beta-stimulated nitric oxide production in cultured rat vascular smooth muscle cells.
Inoue M; Kusano E; Ito C; Akimoto T; Iimura O; Nemoto J; Amemiya M; Muto S; Asano Y
Exp Nephrol; 2002; 10(4):267-74. PubMed ID: 12097830
[TBL] [Abstract][Full Text] [Related]
43. Argininosuccinate synthetase mRNA and activity are induced by immunostimulants in vascular smooth muscle. Role in the regeneration or arginine for nitric oxide synthesis.
Hattori Y; Campbell EB; Gross SS
J Biol Chem; 1994 Apr; 269(13):9405-8. PubMed ID: 7511585
[TBL] [Abstract][Full Text] [Related]
44. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
[TBL] [Abstract][Full Text] [Related]
45. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study.
Lee NP; Cheng CY
Endocrinology; 2003 Jul; 144(7):3114-29. PubMed ID: 12810568
[TBL] [Abstract][Full Text] [Related]
46. Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity.
Fernandes D; da Silva-Santos JE; Duma D; Villela CG; Barja-Fidalgo C; Assreuy J
Mol Pharmacol; 2006 Mar; 69(3):983-90. PubMed ID: 16326931
[TBL] [Abstract][Full Text] [Related]
47. Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms.
Takata M; Filippov G; Liu H; Ichinose F; Janssens S; Bloch DB; Bloch KD
Am J Physiol Lung Cell Mol Physiol; 2001 Feb; 280(2):L272-8. PubMed ID: 11159006
[TBL] [Abstract][Full Text] [Related]
48. Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta.
Moritoki H; Hisayama T; Takeuchi S; Miyano H; Kondoh W
Br J Pharmacol; 1992 Sep; 107(1):196-201. PubMed ID: 1358382
[TBL] [Abstract][Full Text] [Related]
49. Cyclic nucleotides and inducible nitric oxide synthesis in pulmonary artery smooth muscle.
Hayden MA; Nakayama DK
J Surg Res; 1999 Apr; 82(2):222-7. PubMed ID: 10090833
[TBL] [Abstract][Full Text] [Related]
50. Regulation of cGMP-dependent protein kinase expression by soluble guanylyl cyclase in vascular smooth muscle cells.
Browner NC; Dey NB; Bloch KD; Lincoln TM
J Biol Chem; 2004 Nov; 279(45):46631-6. PubMed ID: 15337747
[TBL] [Abstract][Full Text] [Related]
51. Nitric oxide as a signal in thyroid.
Esteves RZ; van Sande J; Dumont JE
Mol Cell Endocrinol; 1992 Dec; 90(1):R1-3. PubMed ID: 1284493
[TBL] [Abstract][Full Text] [Related]
52. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation.
Johns RA; Tichotsky A; Muro M; Spaeth JP; Le Cras TD; Rengasamy A
Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063
[TBL] [Abstract][Full Text] [Related]
53. Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate.
Kibbe MR; Li J; Nie S; Watkins SC; Lizonova A; Kovesdi I; Simmons RL; Billiar TR; Tzeng E
J Vasc Surg; 2000 Jun; 31(6):1214-28. PubMed ID: 10842159
[TBL] [Abstract][Full Text] [Related]
54. Stimulation of nitric oxide-cyclic guanosine monophosphate pathway in bovine ovarian theca cells by tumor necrosis factor alpha (TNF alpha). Is this pathway implicated in the TNF alpha-induced inhibition of luteinizing hormone-stimulated prorenin production?
Brunswig-Spickenheier B; Mukhopadhyay AK
Biol Reprod; 1997 Oct; 57(4):700-6. PubMed ID: 9314569
[TBL] [Abstract][Full Text] [Related]
55. Insulin-like growth factor I inhibits induction of nitric oxide synthase in vascular smooth muscle cells.
Schini VB; Catovsky S; Schray-Utz B; Busse R; Vanhoutte PM
Circ Res; 1994 Jan; 74(1):24-32. PubMed ID: 7505207
[TBL] [Abstract][Full Text] [Related]
56. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans.
Corbett JA; Sweetland MA; Wang JL; Lancaster JR; McDaniel ML
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1731-5. PubMed ID: 8383325
[TBL] [Abstract][Full Text] [Related]
57. Human recombinant erythropoietin inhibits interleukin-1beta-stimulated nitric oxide and cyclic guanosine monophosphate production in cultured rat vascular smooth-muscle cells.
Kusano E; Akimoto T; Inoue M; Masunaga Y; Umino T; Ono S; Ando Y; Homma S; Muto S; Komatsu N; Asano Y
Nephrol Dial Transplant; 1999 Mar; 14(3):597-603. PubMed ID: 10193805
[TBL] [Abstract][Full Text] [Related]
58. Induction of nitric oxide synthase by endotoxin in rat isolated aorta but not in rat aortic smooth muscle cells grown in culture from explant.
McKendrick JD; Paisley K; Eason S; Mian KB; Martin W
Arch Int Pharmacodyn Ther; 1995; 330(2):206-24. PubMed ID: 8861713
[TBL] [Abstract][Full Text] [Related]
59. Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells.
Koide M; Kawahara Y; Tsuda T; Yokoyama M
FEBS Lett; 1993 Mar; 318(3):213-7. PubMed ID: 7680009
[TBL] [Abstract][Full Text] [Related]
60. Role of nitric oxide in antagonistic effects of transforming growth factor-beta and interleukin-1 beta on the beating rate of cultured cardiac myocytes.
Roberts AB; Vodovotz Y; Roche NS; Sporn MB; Nathan CF
Mol Endocrinol; 1992 Nov; 6(11):1921-30. PubMed ID: 1282674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
